000 01428nam a2200361Ia 4500
001 330445
005 20160527193014.0
008 140326t20142014enka b 001 0 eng d
010 _a 2014936696
016 7 _a016747089
_2Uk
020 _a9780124047303
020 _a0124047300
035 _a(OCoLC)ocn809834625
040 _aYDXCP
_beng
_cYDXCP
_erda
_dBTCTA
_dOCLCQ
_dOCLCO
_dTXA
_dBDX
_dOKU
_dUKMGB
_dDLC
042 _alccopycat
050 0 0 _aHD9999.B442
_bB5693 2014
072 7 _aBUS
_x070000
_2bisacsh
082 0 4 _a338.4/766060684
_223
082 0 4 _a338.76606025
_222
092 0 _a338.4
_bB6164b
_b2014
130 0 _aBiotechnology entrepreneurship (Academic Press)
245 1 0 _aBiotechnology entrepreneurship
_bstarting, managing, and leading biotech companies
_cedited by Craig Shimasaki, PhD, MBA, President & CEO, Moleculera Labs and Biosource Consulting Group, Oklahoma City, Oklahoma.
264 1 _aAmsterdam
_aBoston
_bElsevier/AP, Academic Press is an imprint of Elsevier
_c[2014]
264 4 _c©2014
300 _axx, 467 pages
_bcolor illustrations
_c28 cm
336 _btxt
337 _bn
_2rdamedia
338 _bnc
_2rdacarrier
504 _aIncludes bibliographical references and index.
650 0 _aBiotechnology industries
_xManagement.
_962504
_2Local
650 0 _aEntrepreneurship
_992320
_2Local
700 1 _aShimasaki, Craig D.
_eeditor.
_9276752
_2Local
999 _c247160
_d247160